Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF -1-
October 28, 2002
- REGULATORY NEWS IN BRIEF -2-
October 28, 2002
- WMA General Assembly Washington 2002
October 28, 2002
- Profit-Making Companies to Not Be Allowed to Operate Medical Facilities
October 28, 2002
- ED Awareness Campaign Successful: Pfizer
October 28, 2002
- JMA Strongly Opposed Operation of Hospitals by Profit-making Corporations
October 28, 2002
- BULLETIN
October 28, 2002
- Most Deregulations Proposed by Korosho Approved
October 28, 2002
- Asahi Kasei to Pursue "Selection and Concentration" Policy
October 28, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 28, 2002
- Sumitomo Chemical, Takeda to Establish New Agrochemical JV
October 28, 2002
- Ingredients in Ashitaba Effective for Osteoporosis: Takara Bio
October 28, 2002
- Suzuken Ties Up with Ando Chemical Works
October 28, 2002
- Cloned Cow for Organ Transplantation Produced by TWMU, ZEN-NOH
October 28, 2002
- WEBSITE NEWS
October 28, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
October 28, 2002
- BUSINESS NEWS IN BRIEF
October 28, 2002
- Matsumotokiyoshi Ties Up with Koyo Yakuhin
October 28, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
October 28, 2002
- Interim Report Drafted on Promotion of OTC Drugs
October 28, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…